Clinical trial
Study of the Effectiveness of Additional Reductions in Cholesterol and…
NCT00124072 · University of Oxford, Other · Completed
Key facts
| NCT number | NCT00124072 |
|---|---|
| Title | Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine |
| Official title | SEARCH: Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine |
| Acronym | SEARCH |
| Lead sponsor | University of Oxford, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Disease |
| Intervention type | Dietary Supplement, Drug |
| Interventions | Simvastatin 20 mg daily, Folic acid 2 mg + vitamin B12 1 mg daily, Simvastatin 80 mg daily, Placebo |
| Enrollment | 12,064 |
| Start date | Jul 1, 1998 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jul 26, 2005 |
| Last update posted | Feb 1, 2012 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: